https://www.selleckchem.com/pr....oducts/halofuginone.
To report the 10-year outcomes of eyes with neovascular age-related macular degeneration (nAMD) treated with vascular endothelial growth factor (VEGF) inhibitors. Ten-year, retrospective cohort study. A total of 1046 patients who commenced treatment with anti-VEGF for nAMD. Anti-VEGF-naïve eyes diagnosed with nAMD that commenced treatment between November 2006 and December 2009 were identified. Data collected included the baseline demographics, visual acuity (VA), and number of intravitreal injections. Baseline fundus fluorescein a
Like
Comment
Share
